advertisement
Journal of Ocular Pharmacology and Therapeutics 28
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Ozkurt YB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Kim YI
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Halkiadakis I
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Scavelli K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Akkaya S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Adachi M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Kim JH
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Kontadakis GA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Chatterjee A
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Hamada N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Rhee DJ
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee TY
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Aksoy S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Tesavibul N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Tsiakou D
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Honda N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Patsea E
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Evciman T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Thewthong M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee KW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Mitropoulos P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Koseki N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
